Effects of EPA supplementation on plasma fatty acids composition in hypertriglyceridemic subjects with FABP2 and PPARα genotypes

Journal of Diabetes and Metabolic Disorders

Volumn 11, Issue 1, 2012, Pages

  Pishva, Hamideh ^a   Amini, Mohsen ^b   Eshraghian, Mohammad Reza ^c   Hosseini, Saeed ^d   Mahboob, Soltan Ali ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Eicosapentaenoic acid; Fatty acid binding protein 2; Peroxisome proliferator activated receptor; Plasma fatty acids composition; Polymorphism

Indexed keywords

11 ECOSENOIC ACID; 11, 14 ECOSADIENOIC ACID; 15 TETRACOSENOIC ACID; ALANINE; ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; DIHOMO GAMMA LINOLENIC ACID; FATTY ACID BINDING PROTEIN 2; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LEUCINE; LINOLEIC ACID; MIRISTIC ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; THREONINE; UNCLASSIFIED DRUG; VALINE;

ARTICLE; DRUG EFFECT; EXON; FATTY ACID BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; INTRON; LIPID COMPOSITION; PLASMA FATTY ACIDS COMPOSITION; SUPPLEMENTATION; TREATMENT DURATION; AMINO ACID SUBSTITUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; GENETIC VARIABILITY; HETEROZYGOTE; TREATMENT RESPONSE;

EID: 84885349942     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-11-25     Document Type: Article

References (39)

1. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747-2757. 10.1161/01.CIR.0000038493.65177.94, 12438303.
2. Arab L. Biomarkers of fat and fatty acid intake. J Nutr 2003, 133(Suppl 3):925S-932S.
3. Kohlmeier L. Future of dietary exposure assessment. Am J Clin Nutr 1995, 61(3 Suppl):702S-709S.
4. Rossner S, Walldius G, Bjorvell H. Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes 1989, 13(5):603-612.
5. Phinney SD, Tang AB, Thurmond DC, Nakamura MT, Stern JS. Abnormal polyunsaturated lipid metabolism in the obese Zucker rat, with partial metabolic correction by gamma-linolenic acid administration. Metabolism: clinical and experimental 1993, 42(9):1127-1140.
6. Scaglioni S, Verduci E, Salvioni M, Bruzzese MG, Radaelli G, Zetterstrom R, Riva E, Agostoni C. Plasma long-chain fatty acids and the degree of obesity in Italian children. Acta Paediatr 2006, 95(8):964-969. 10.1080/08035250600764834, 16882570.
7. Agostoni C, Riva E, Bellu R, Vincenzo SS, Grazia BM, Giovannini M. Relationships between the fatty acid status and insulinemic indexes in obese children. Prostaglandins Leukot Essent Fatty Acids 1994, 51(5):317-321. 10.1016/0952-3278(94)90003-5, 7846102.
8. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000, 35(12):1305-1312. 10.1007/s11745-000-0646-3, 11201991.
9. Heude B, Ducimetiere P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes-The EVA Study. Am J Clin Nutr 2003, 77(4):803-808.
10. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003, 89(4):483-489. 10.1079/BJN2002804, 12654166.
11. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Goldbourt U, Greenland P. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke; a journal of cerebral circulation 2004, 35(7):1538-1542. 10.1161/01.STR.0000130856.31468.47, 23560284.
12. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004, 93(9):1119-1123. 10.1016/j.amjcard.2004.01.038, 15110203.
13. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004, 109(22):2705-2711. 10.1161/01.CIR.0000132503.19410.6B, 15184295.
14. Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S, Stuehlinger M, Morrow J, Ridker P, Rifai N, Mietus-Snyder M. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther 2004, 42(12):672-679.
15. Engler MM, Engler MB, Malloy MJ, Paul SM, Kulkarni KR, Mietus-Snyder ML. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 2005, 95(7):869-871. 10.1016/j.amjcard.2004.12.014, 15781019.
16. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354(9177):447-455. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
17. Aro A. Fatty acid composition of serum lipids: is this marker of fat intake still relevant for identifying metabolic and cardiovascular disorders?. Nutr Metab Cardiovasc Dis 2003, 13(5):253-255. 10.1016/S0939-4753(03)80028-5, 14717056.
18. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clinical nutrition (Edinburgh, Scotland) 2004, 23(4):447-456.
19. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 2000, 83(Suppl 1):S91-96.
20. Pishva H, Mahboob SA, Mehdipour P, Eshraghian MR, Mohammadi-Asl J, Hosseini S, Karimi F. Fatty acid-binding protein-2 genotype influences lipid and lipoprotein response to eicosapentaenoic acid supplementation in hypertriglyceridemic subjects Burbank, Los Angeles County, Calif: Nutrition.
21. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226(1):497-509.
22. Wang Y, Sunwoo H, Cherian G, Sim JS. Fatty acid determination in chicken egg yolk: a comparison of different methods. Poult Sci 2000, 79(8):1168-1171.
23. Pishva H, Mahboob SA, Mehdipour P, Eshraghian MR, Mohammadi-Asl J, Saeed Hosseini M, Rahmany M. Association between the FABP2 Ala54Thr, PPARa Leu162/Val, and PPARa intron7 polymorphisms and blood lipids, ApoB and ApoCIII in hypertriglyceridemic subjects in Tehran. J Clin Lipidol 2009, 3(2009):2187-2194.
24. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995, 95(3):1281-1287. 10.1172/JCI117778, 441467, 7883976.
25. Kim CH, Yun SK, Byun DW, Yoo MH, Lee KU, Suh KI. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men. Metabolism: clinical and experimental 2001, 50(4):473-476.
26. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997, 66(3):649-659.
27. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002, 76(5):1007-1015.
28. Nestel P, Shige H, Pomeroy S, Cehun M, Abbey M, Raederstorff D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 2002, 76(2):326-330.
29. King IB, Lemaitre RN, Kestin M. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr 2006, 83(2):227-236.
30. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83(6 Suppl):1467S-1476S.
31. Haban P, Zidekova E, Klvanova J. Supplementation with long-chain n-3 fatty acids in non-insulin-dependent diabetes mellitus (NIDDM) patients leads to the lowering of oleic acid content in serum phospholipids. Eur J Nutr 2000, 39(5):201-206. 10.1007/PL00007379, 11131366.
32. Horrobin DF. Interactions between n-3 and n-6 essential fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation. Prostaglandins Leukot Essent Fatty Acids 1991, 44(2):127-131. 10.1016/0952-3278(91)90196-C, 1745654.
33. Berstad P, Seljeflot I, Veierod MB, Hjerkinn EM, Arnesen H, Pedersen JI. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin Sci (Lond) 2003, 105(1):13-20.
34. Holler C, Auinger M, Ulberth F, Irsigler K. Eicosanoid precursors: potential factors for atherogenesis in diabetic CAPD patients?. Perit Dial Int 1996, 16(Suppl 1):S250-253.
35. Hlavaty P, Kunesova M, Gojova M, Tvrzicka E, Vecka M, Roubal P, Hill M, Hlavata K, Kalouskova P, Hainer V, Zak A, Drbohlav J. Change in fatty acid composition of serum lipids in obese females after short-term weight-reducing regimen with the addition of n-3 long chain polyunsaturated fatty acids in comparison to controls. Physiological research/Academia Scientiarum Bohemoslovaca 2008, 57(Suppl 1):S57-65.
36. Vidgren HM, Sipilainen RH, Heikkinen S, Laakso M, Uusitupa MI. Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur J Clin Invest 1997, 27(5):405-408. 10.1046/j.1365-2362.1997.1320679.x, 9179548.
37. Pratley RE, Baier L, Pan DA, Salbe AD, Storlien L, Ravussin E, Bogardus C. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 2000, 41(12):2002-2008.
38. Hirai A, Hamazaki T, Terano T, Nishikawa T, Tamura Y, Kamugai A, Jajiki J. Eicosapentaenoic acid and platelet function in Japanese. Lancet 1980, 2(8204):1132-1133.
39. Hegele RA, Young TK, Connelly PW. Are Canadian Inuit at increased genetic risk for coronary heart disease?. J Mol Med (Berlin, Germany) 1997, 75(5):364-370.